Management of Dizziness with Hypoplastic Vertebral Artery
Begin with a thorough clinical history to distinguish between vertebrobasilar insufficiency and other causes of dizziness, then initiate antiplatelet therapy with aspirin 81-325 mg daily along with aggressive atherosclerotic risk factor modification, as hypoplastic vertebral artery can predispose to posterior circulation ischemia when additional vascular risk factors coexist 1, 2.
Critical First Step: Differentiate the Cause of Dizziness
Your patient's dizziness could be from multiple etiologies—vertebrobasilar insufficiency (VBI), vestibular disorders, cardiac arrhythmias, or orthostatic hypotension 1. The hypoplastic vertebral artery is a congenital anatomic variant found in 2-6% of the population 3, and while it can be an independent risk factor for reduced posterior circulation blood flow, it doesn't automatically mean the dizziness is vascular in origin.
Key clinical features that suggest VBI rather than benign causes:
- Associated symptoms: diplopia, perioral numbness, blurred vision, ataxia, bilateral sensory deficits, or syncope 1
- Symptoms triggered by head turning or neck positioning 1, 4
- Duration of episodes: typically 1-60 minutes 5
- Presence of vascular risk factors: hypertension, diabetes, hyperlipidemia, smoking 2
Common pitfall: Isolated dizziness alone has a very low yield (approximately 4%) for posterior circulation ischemia on imaging 6. Don't assume the hypoplastic vertebral artery is causative without additional supporting features.
Imaging Already Completed—What It Tells You
You already have MRA showing the hypoplastic vertebral artery. The guidelines recommend MRA or CTA over ultrasound for evaluating vertebral arteries in patients with posterior circulation symptoms 1.
What you need to assess on the existing MRA:
- Is there significant stenosis (≥50%) in addition to the hypoplasia?
- Is the contralateral vertebral artery normal or also compromised?
- What is the status of the basilar artery?
- Is the circle of Willis complete or incomplete? 7
The hypoplastic artery becomes clinically significant when it limits compensatory blood flow, particularly if there's occlusion or stenosis elsewhere in the posterior circulation 3, 8.
Medical Management: The Foundation of Treatment
Regardless of whether the dizziness is definitively from VBI, if your patient has a hypoplastic vertebral artery with symptoms suggestive of posterior circulation involvement, treat as you would vertebral artery disease 1. The guidelines explicitly state that despite limited specific evidence for vertebral artery disease, medical management should follow the same principles as carotid artery disease 1.
Antiplatelet Therapy (Class I Recommendation)
- Start aspirin 81-325 mg daily 1
- If aspirin is contraindicated (allergy, not active bleeding), use clopidogrel 75 mg daily or ticlopidine 250 mg twice daily 1
- Recent evidence shows 93.2% reduction in attacks with antiplatelet therapy in vertebrobasilar TIA patients 5
Aggressive Risk Factor Modification
- Statin therapy: Target LDL reduction regardless of baseline cholesterol 2
- Blood pressure control: Critical, as hypertension significantly increases risk (note the case report with BP 200/120 mm Hg) 2
- Diabetes management if present
- Smoking cessation
When to Consider Additional Workup
You must exclude other causes of dizziness before attributing symptoms solely to the hypoplastic vertebral artery:
- Cardiac evaluation: ECG, echocardiogram, 24-hour Holter monitoring to rule out arrhythmias 2
- Orthostatic vital signs: Rule out orthostatic hypotension 1
- Vestibular testing: Consider Dix-Hallpike maneuver if BPPV is suspected 6
- Transcranial Doppler ultrasound: Can demonstrate flow differences in VBI patients versus other causes of vertigo 6
Serial Imaging Considerations
If symptoms persist or worsen despite medical therapy, consider serial noninvasive imaging (Class IIa recommendation) 1. This assesses for:
- Progression of atherosclerotic disease
- Development of new stenotic lesions
- Changes in collateral circulation
Repeat imaging at 6-12 month intervals is reasonable, similar to post-carotid revascularization protocols 1.
When Revascularization Might Be Considered
Revascularization is rarely indicated for vertebral artery disease and has not been evaluated in randomized trials 1. Consider referral to a neurovascular specialist only if:
- Recurrent posterior circulation TIAs despite optimal medical therapy
- Documented significant stenosis (≥50%) in addition to hypoplasia
- Catheter-based angiography may be needed to define anatomy if noninvasive imaging is inadequate 1
Important caveat: The evidence for intervention is weak, and medical management remains the primary approach 1.
Prognosis and Patient Counseling
With appropriate medical management, the prognosis is generally favorable. In a recent prospective study, 93.2% of patients with vertebrobasilar TIA had reduction in attacks with antiplatelet therapy, with only 6.8% experiencing recurrence during follow-up 5. However, annual stroke rates for symptomatic vertebral artery stenosis are approximately 8% 1, emphasizing the importance of aggressive risk factor modification.
The hypoplastic vertebral artery itself is a congenital variant that becomes clinically relevant primarily when additional vascular risk factors coexist 2, 3. Your focus should be on optimizing modifiable risk factors rather than the anatomic variant itself.